1. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F]2-deoxy-2-fluoro-D-glucose;Gallagher;J Nucl Med,1978
2. The applications of PET in clinical oncology;Strauss;J Nucl Med,1991
3. The promise of FDG in diagnosis and surveillance of head and neck cancer;Mancuso;Cancer,1994
4. FDG-PET for metabolic classification of residual lymphoma masses after chemotherapy;Bares;J Nucl Med,1994
5. Glucose utilisation of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography;DiChiro;Neurology,1982